McFarlane Neil F. 4
4 · ZEVRA THERAPEUTICS, INC. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
McFarlane Neil F.
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2025-02-13$7.86/sh−61,273$481,428→ 222,060 total - Sale
Common Stock
2025-02-14$8.05/sh−30,544$245,962→ 191,516 total
Footnotes (1)
- [F1]Adoption date of referenced 10b5-1(c) plan is: 10-15-2024